𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells

✍ Scribed by Kursad Genc; Mehtap Y. Egrilmez; Sermin Genc


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
127 KB
Volume
28
Category
Article
ISSN
0263-6484

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Erythropoietin (Epo) exerts neuroprotective, glioprotective, and vascular protective effects in the nervous system. However, the mechanisms of the cytoprotective effect of Epo have not been fully clarified. Here, we investigated whether Epo affects the transcription and activation of nuclear factor erythroid 2‐related factor 2 (Nrf2), which is a key transcription factor of the cellular anti‐oxidant defense system, and mRNA expression of its target genes including heme oxygenase‐1 (HO‐1). Epo was added to SH‐SY5Y cells at 1 U mL^−1^ and cultures were incubated for 24 h and then mRNA expression of Nrf2 target genes were analyzed with real‐time PCR. SH‐SY5Y cells were incubated with Epo at different time points and the nuclear and cytoplasmic levels of Nrf2 protein expression were examined by Western blotting and immunohistochemistry. Specific inhibitors of mitogen‐activated protein kinases (MAPKs) and phosphatidylinositol‐3 kinase (PI3K) were used to find out the possible signaling pathways that mediate the activating effect of Epo on Nrf2 activation. In cultured human SH‐SY5Y neuroblastoma cells, Western blotting, immunohistochemistry, and real‐time PCR analysis demonstrated that Epo‐induced nuclear translocation of Nrf2 and upregulates HO‐1 expression. Inhibitors of MAPKs and PI3K decreased Epo‐induced nuclear translocation of Nrf2 and HO‐1 mRNA expression. These results suggest that Epo induces neural HO‐1 expression through the activation of PI3K, MAPK, and Nrf2 pathways, and this may unveil a novel mechanism which mediates the cytoprotective responses elicited by Epo. Copyright © 2010 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


C-terminal mechano-growth factor induces
✍ Arnulfo Quesada; Julie Ogi; James Schultz; Adrian Handforth 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Recently, a variant of insulin-like growth factor-1, mechano-growth factor (MGF), has been discovered whose 24-amino-acid carboxy end is protective in models of stroke, nerve injury, and amyotrophic lateral sclerosis, suggesting broad-spectrum neuroprotective properties. Moreover, we recently demons

PI3K and ERK/Nrf2 pathways are involved
✍ Jian Feng; Ping Zhang; Xuxin Chen; Guoxiang He 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Oleanolic acid (OA), a widely used plant-derived triterpenoid, has been shown to possess potent antiatherosclerotic effects, which may be associated with the induction of heme oxygenase-1 (HO-1). However, the underlying mechanisms involved in the effect of OA on HO-1 expression are unclear. In the c

Caspases-2, -3, and -7 are involved in t
✍ Mary K. Dahmer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

## Abstract Caspase‐2 has been reported to play a role in the cell death observed under a number of different conditions; however, it is unclear whether caspase‐2 plays a role in cell death triggered by endoplasmic reticulum (ER) stress. The purpose of this study was to determine whether caspase‐2

Neuritogenesis induced by vasoactive int
✍ Céline Héraud; Sandrine Hilairet; Jean-Marc Muller; Jean-François Leterrier; Cor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Vasoactive intestinal peptide (VIP) and the related peptides pituitary adenylate cyclase‐activating polypeptide (PACAP) and peptide histidine methionine (PHM) are known to regulate proliferation and/or differentiation in normal and tumoral cells. In this study, neuritogenesis in human n